- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
KAEF
JKT
Week ended 07 Aug 2026
Weekly Investor Report
PT Kimia Farma Tbk · Healthcare · Medical Distribution
Latest close
460.0 IDR
1.8%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -5.6% below the Trend Line and sits at 14.2% of its 52-week range. The latest completed week returned 1.8%, after a 1.3% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
25
out of 100
Latest Close
460.0 IDR
7 Aug 2026
1W Return
1.8%
latest completed week
4W Return
1.3%
short-term follow-through
12W Return
-23.3%
quarterly tape
Trend Breadth
9.6%
5 of 52 weeks active
Volume Ratio
0.1x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
1.8%
Latest completed week; four-week move 1.3%.
Indicator stack
5/39
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 38.44%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
5 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -5.6% below the Trend Line and sits at 14.2% of its 52-week range. The latest completed week returned 1.8%, after a 1.3% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.1x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0412-week average 0.12
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure4/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.04Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 1.3% over four weeks, -23.3% over 12 weeks, and -12.4% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year5
Trend breadth9.6%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.41Latest activity-pressure read.
Pressure change-41.6%Four-week change in activity pressure.
Leadership4.93Latest relative-leadership reading.
RS change-59.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 5 relevant articles.
0 positive · 5 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-41.4%Distance below the 52-week high.
13-week volatility7.4%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher8 of 2616 weeks finished lower.
Best week+32.8%Week of 8 May.
Worst week-19.7%Week of 22 May.
Latest week+1.8%Week of 7 Aug.
Shape of recent returns
Strong gains3
Modest gains5
Flat weeks2
Modest losses11
Sharp losses5
Recent vol7.4%13-week weekly-return volatility.
Base vol6.9%52-week weekly-return volatility.
Up/down split17/30Count of positive and negative weeks in the 52-week window.
Average skew6.1% / -3.5%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorID Healthcare
4-week rank26 / 38
Group average4.5%
Trend breadth15.8%
Trend15.8%active weekly trend signals
MD44.7%positive activity pressure
RS73.7%positive relative leadership
Four-week leaders
IndustryID Medical Distribution
4-week rank4 / 6
Group average1.2%
Trend breadth16.7%
Trend16.7%active weekly trend signals
MD16.7%positive activity pressure
RS83.3%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape24/100
Trend, activity pressure, participation, and risk combine to a 24/100 tape read.
Indicator analysis35/100Latest 12-week confirmation: trend 0/12, activity pressure 4/12, relative leadership 12/12.
Activity pressure 0.04; No reversal markers Next-Week ExpectancyNegative 38.44%Next-week expectancy is negative with a 38.44% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 5 relevant articles.
Kimia Farma clarifies regarding 2026 international arbitration dispute Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 460.0 IDR | 1.8% | 487.2 IDR | 643.7 IDR | -0.41 | 4.93 | 2.3M | Off |
| 31 Jul 2026 | 452.0 IDR | 0.0% | 490.5 IDR | 646.1 IDR | -0.39 | 6.04 | 1.4M | Off |
| 24 Jul 2026 | 452.0 IDR | -0.9% | 492.8 IDR | 648.6 IDR | -0.37 | 6.86 | 2.7M | Off |
| 17 Jul 2026 | 456.0 IDR | 0.4% | 495.0 IDR | 651.2 IDR | -0.30 | 8.27 | 2.1M | Off |
| 10 Jul 2026 | 454.0 IDR | 1.8% | 497.7 IDR | 653.7 IDR | -0.29 | 12.30 | 12.6M | Off |
| 3 Jul 2026 | 446.0 IDR | -2.2% | 500.5 IDR | 655.8 IDR | -0.29 | 10.82 | 300.2K | Off |
| 26 Jun 2026 | 456.0 IDR | 3.2% | 504.3 IDR | 658.0 IDR | -0.32 | 12.20 | 485.9K | Off |
| 19 Jun 2026 | 442.0 IDR | -0.5% | 507.1 IDR | 660.0 IDR | -0.21 | 3.22 | 569.4K | Off |
| 12 Jun 2026 | 444.0 IDR | 9.4% | 511.4 IDR | 662.2 IDR | 0.00 | 5.84 | 531.5K | Off |
| 5 Jun 2026 | 406.0 IDR | -15.4% | 515.6 IDR | 663.9 IDR | 0.42 | 3.29 | 720.7K | Off |
| 29 May 2026 | 480.0 IDR | -0.4% | 521.4 IDR | 665.9 IDR | 0.88 | 11.12 | 6.6M | Off |
| 22 May 2026 | 482.0 IDR | -19.7% | 525.6 IDR | 667.9 IDR | 0.73 | 11.07 | 44.9M | Off |
| 15 May 2026 | 600.0 IDR | -5.5% | 530.3 IDR | 670.2 IDR | 0.57 | 26.82 | 124.8M | Off |
| 8 May 2026 | 635.0 IDR | 32.8% | 530.5 IDR | 671.9 IDR | 0.19 | 30.34 | 64.5M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.